Search

In Stock

Buy Vascepa (icosapent ethyl) Online

DISEASE INDICATIONS: Risk of cardiovascular events, Hypertriglyceridemia

MANUFACTURER: Amarin Pharma Inc

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Vascepa (icosapent ethyl) is a medication used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or elevated triglyceride levels.

From $530.34

Clear
Compare

Vascepa (icosapent ethyl) is a prescription medication used to reduce the risk of cardiovascular events, including heart attack, stroke, and death, in adults with established cardiovascular disease or with elevated triglyceride levels. Vascepa is a capsule that is taken orally with food.

Uses:

Vascepa is used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or with elevated triglyceride levels.

Storage Conditions:

Vascepa should be stored in a cool and dry place, at a temperature of 20°C to 25°C (68°F to 77°F).

Mechanism of Action:

Vascepa is a type of omega-3 fatty acid that contains only eicosapentaenoic acid (EPA) and is free from docosahexaenoic acid (DHA). EPA has been shown to reduce inflammation and plaque buildup in the arteries, which can reduce the risk of cardiovascular events.

HOW TO USE:

Vascepa should be taken orally with food. The recommended dose is 4 grams per day, either as a single 4-gram capsule or as two 2-gram capsules twice daily.

Important Safety Information:

• Vascepa may cause serious allergic reactions, such as anaphylaxis, which are potentially life-threatening. Patients should seek emergency medical attention immediately if they experience symptoms of an allergic reaction, such as difficulty breathing, swelling of the face, lips, tongue, or throat, or severe itching or skin rash.
• The medication may interact with other medications, such as anticoagulants, and increase the risk of bleeding. Patients should inform their healthcare provider of all medications they are taking, including supplements and herbal remedies.
• Vascepa may increase the risk of bleeding, and patients who have a bleeding disorder or who take anticoagulant medications should use the medication with caution.
• The medication may also increase the risk of pancreatitis, and patients should discontinue the medication if they develop symptoms of pancreatitis, such as severe abdominal pain.

Indications:

• Vascepa is indicated as an adjunct to diet to reduce the risk of cardiovascular events in adults with elevated triglyceride levels of 150 mg/dL or higher and established cardiovascular disease, or diabetes mellitus and two or more additional risk factors for cardiovascular disease.

Precautions:

• Patients with a history of hypersensitivity to icosapent ethyl or any of its components should not take Vascepa.
• The medication should be used with caution in patients with hepatic impairment or severe renal impairment.

Interactions:

• Vascepa may interact with other medications, such as anticoagulants, and increase the risk of bleeding.
• Patients should inform their healthcare provider of all medications they are taking, including supplements and herbal remedies, before starting treatment with Vascepa.

Contraindications:

• Vascepa is contraindicated in patients with a hypersensitivity to icosapent ethyl or any of its components.

Overdose:

There is no specific antidote for Vascepa. In case of an overdose, patients should seek emergency medical attention immediately.

Side Effects:

The most common side effects of Vascepa include joint pain, muscle pain, and flu-like symptoms. Other possible side effects may include gastrointestinal symptoms, such as diarrhea, hyperglycemia, and atrial fibrillation. Patients should notify their healthcare provider if they experience any unusual symptoms while taking Vascepa.

In conclusion, Vascepa is a medication used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or with elevated triglyceride levels. It contains only eicosapentaenoic acid (EPA) and is free from docosahexaenoic acid (DHA), which has been shown to reduce inflammation and plaque buildup in the arteries. Patients should take the medication orally with food, and the recommended dose is 4 grams per day. Vascepa may cause serious allergic reactions and increase the risk of bleeding and pancreatitis. The medication should be used with caution in patients with hepatic impairment or severe renal impairment and is contraindicated in patients with a hypersensitivity to icosapent ethyl or any of its components. Patients should inform their healthcare provider of all medications they are taking, including supplements and herbal remedies. Vascepa should be stored in a cool and dry place, at a temperature of 20°C to 25°C (68°F to 77°F).

Package

120 gelatine capsules of 1 g, 240 gelatine capsules of 0.5 g

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Orladeyo (berotralstat) Online

$17,967.38
(0 Reviews)
MANUFACTURER: BioCryst Pharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Orladeyo is a prescription medication used to prevent attacks of hereditary angioedema in adults and children by reducing the frequency of attacks. It is a subcutaneous injection that works by inhibiting kallikrein, an enzyme involved in the production of bradykinin.

Buy Verquvo (vericiguat) Online

From $284.99
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Merck USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.

Buy Repatha SureClick (evolocumab) Online

$629.98
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypercholesterolemia MANUFACTURER: Amgen Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Repatha is a subcutaneous injection used to lower LDL cholesterol levels in adults with primary hyperlipidemia or mixed dyslipidemia and in individuals with clinical atherosclerotic cardiovascular disease who require additional LDL cholesterol reduction. It binds to and inhibits PCSK9, promoting the clearance of LDL cholesterol from the bloodstream.

Buy Vascepa (icosapent ethyl) Online

From $530.34
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypertriglyceridemia MANUFACTURER: Amarin Pharma Inc USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Vascepa (icosapent ethyl) is a medication used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or elevated triglyceride levels.

Buy Entresto (sacubitril/valsartan) Online

From $148.92
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.

Buy Nexletol (bempedoic acid) Online

$426.42
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Esperion Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Nexletol is a prescription medication used to lower cholesterol levels in patients with hypercholesterolemia.

Back to Top
Product has been added to your cart